Petersen MB et al., 2000: Intravenous and oral pharmacokinetic study in pigs. Oral bioavailability of fenbendazole was 27.1%, and oxfendazole accounted for about two-thirds of total plasma exposure.
Oxfendazole was the major plasma metabolite, accounting for two-thirds of the total area under the plasma concentration versus time curve after IV and oral administration.
Petersen MB et al., 2000: Intravenous and oral pharmacokinetic study in pigs. Oral bioavailability of fenbendazole was 27.1%, and oxfendazole accounted for about two-thirds of total plasma exposure. Animal PK study; 4 female pigs, 32-45 kg; Denmark (Royal Veterinary and Agricultural University, Copenhagen); 1 mg/kg IV then 5 mg/kg oral, blood sampling to 72 h. Funder: not stated; no grant list. Declared conflicts: none recorded. Product: fenbendazole, manufacturer not stated. Comparator: IV versus oral in the same animals. Typical pig data behind the 'low oral bioavailability' statement in C1. Study type: animal.
